| Date & Time | 13 January 2026 |
|---|---|
| Location | Webinar |
Be part of the conversation shaping the future of rare disease research!
Join our first webinar to learn how RealiseD is pioneering a collaborative and comprehensive approach to clinical trials in ultra-rare diseases. During the webinar, we’ll walk you through the project’s objectives, structure, and methodologies—and show how you can be part of this transformative journey.
This interactive session will:
- Delve into the unique challenges in URD trials
- Spark collaboration from the very beginning
- Define current obstacles and explore practical solutions
- Align on shared principles for interpreting URD data
Agenda
- Introduction – by Kathy Williams, Executive Director, Global Regulatory Affairs, AstraZeneca, and RealiseD project lead
- Presentation – by Ralf-Dieter Hilgers, Professor at SFU and RealiseD coordinator
- Discussion Pannel
- Solange Corriol – Independent consultant in Regulatory Affairs and Policy
- Donato Bonifazi – CEO of Consorzio per Valutazioni Biologiche e Farmacologiche
- Helene Le Borgne – Policy Officer at European Commission
- Audience Q&A
- Closure
About the project: The RealiseD project, funded by the Innovative Health Initiative (IHI), aims to develop a collaborative and comprehensive methodological and operational framework to improve how clinical trials are designed and conducted in ultra-rare diseases.During this webinar, we will present the project’s objectives, structure, and innovative approaches, offering participants an opportunity to learn about current challenges and emerging solutions for evidence generation in ultra-rare disease research.
